Trial · NCT01864603
Outcomes17
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Cumulative HIV Incidence | 3 years follow up | Baseline HIV- stable adult (15+years) residents | cumulative events per 100 persons | MEAN |
| PRIMARY | HIV Incidence | 3 years follow up | Intervention population consists of persons aged 15+ years who initiated PrEP in Phase II intervention communities. The comparator population consists of propensity score matched historical controls from Phase I intervention communities. HIV testing was not comprehensively conducted during Phase 2. | Incident HIV per 100 person-year | NUMBER |
| SECONDARY | Incident TB Associated With HIV | 3 years follow up | Adults without active TB and with HIV at baseline | cumulative events per 100 persons | MEAN |
| SECONDARY | Overall Mortality | 3 years follow up | Known HIV+ at baseline | cumulative events per 100 persons | MEAN |
| SECONDARY | HIV-free Infant Survival | 3 years follow up | Infants born in study period to women with HIV | cumulative events per 100 persons | MEAN |
| SECONDARY | Percent of HIV+ Adults With HIV RNA <=500 c/mL | 3 years follow up | HIV+ adults at year 3, including those out of care or without a prior HIV diagnosis | cumulative events per 100 persons | MEAN |
| SECONDARY | Time in Care for HIV+ Adults With Baseline Viremia | 3 years follow up | HIV+ adults linked to care with baseline HIV RNA \>=500 c/mL | percentage of days | MEAN |
| SECONDARY | Cumulative Incidence of ART-initiation | 3 years follow up | Baseline HIV+ without previous or current ART | cumulative events per 100 persons | MEAN |
| SECONDARY | Hypertension Control | 3 years follow up | Hypertensive adults (aged 30+) at year 3 | cumulative events per 100 persons | MEAN |
| SECONDARY | Adherence to PrEP Treatment | 3 years follow up | Persons who initiated PrEP eligible for a follow-up visit. No data were collected for the second stage in the control arm due to DSMB approved design modification. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Average Adults' on- and Off-farm Employment | 3 years follow up | Subsample of baseline HIV+ working-age adults (18-65) | cumulative events per 100 persons | MEAN |
| SECONDARY | Year 3 Viremia Among ART-experienced Persons With Baseline Viremia | 3 years follow up | HIV+ ART experienced adults linked to care with baseline HIV RNA \>=500 c/mL | cumulative events per 100 persons | MEAN |
| SECONDARY | Linkage to Care | 30 days after HIV test | Persons testing HIV+ and not in care | cumulative events per 100 persons | MEAN |
| SECONDARY | HIV Incidence Rate | 3 years follow up | HIV-negative adults in stage 1 intervention arm who had repeat HIV testing | per 100 person-years | NUMBER |
| SECONDARY | Prevalence of Transmitted HIV Drug-resistance Mutations | Baseline | ART naive HIV+ persons at baseline | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Prevalence of Chronic Kidney Disease (CKD) | 3 years follow up | participants (age \>=18) who had a home visit during follow up year 3 | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Total Costs of Programming (ART) | Follow up year 3 | Units are Intervention clinics using streamlined care; participants are HIV+ with at least one streamlined care visit | USD per person year | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01864603/outcomes